Biology of HPV-Related Cancers and New Vaccine Strategies for Control and Treatment
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Epidemiology of Infectious Diseases".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 339
Special Issue Editors
Interests: nucleic acid vaccine; yeast-based vaccines; application of immunoinformatics in novel vaccine design; development and evaluation of HPV therapeutic; vaccine Zika; viral pathogenesis; Vaccine delivery
Special Issues, Collections and Topics in MDPI journals
Interests: HPV; polyomavirus; virus-associated cancer; immunotherapy; therapeutic vaccines; preventive vaccines; DNA vaccines; anticancer vaccines; electroporation; in situ vaccine
Interests: oncogenes; cancer research; immunology; cell biology
Special Issue Information
Dear Colleagues,
It is well known that human papillomavirus (HPV) has an established causal relationship with cervical and oropharyngeal cancer development; however, since the 1970s, several studies have pointed to the presence and effect of HPV in different body sites, such as the lungs, breast, blood, and mouth. For most non-anogenital HPV-related cancers, evidence of the correlation between infection and tumor formation and identification of how HPV might be affecting a cancer patient's treatment and outcome are still necessary to improve cancer prevention and move forward to individualized and effective patient care. Although prophylactic vaccines against HPV infection are available today, they do not prevent the infection of all types of oncogenic HPV. In addition, the available vaccine is not effective against established infections. In addition, the current treatments against HPV-related cancers have low efficiency and the search for effective therapies is a topic of high relevance for scientific investigation as a global public health matter. In this context, the so-called advanced therapies (gene/cell therapy and therapeutic vaccines) have been the target of game-changing research.
This Special Issue welcomes submissions across the broadest interpretation of the points, including, but not restricted to, the following:
- HPV and lung cancer;
- HPV and breast cancer;
- HPV and head–neck cancer;
- HPV and skin cancer;
- HPV and cervix cancer;
- HPV-related cancer therapeutic vaccine (DNA vaccine, RNAm vaccine, dendritic cell vaccine and whole-cell vaccine).
Prof. Dr. Antônio Carlos F. De Freitas
Prof. Dr. Aldo Venuti
Dr. Anna Silva
Dr. Talita Helena Araújo De Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV
- cancers
- vaccine
- vaccine strategies
- control
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
